Your SlideShare is downloading. ×
Investment framwork tanzania_cs-powerpoint
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Investment framwork tanzania_cs-powerpoint

295
views

Published on

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
295
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. !"#$%"&#$()*$#)"+,-*$%.,/"0.,")1$"2$(3.#($")."!&45" " 6.,$"7-89$"0.,")1$"6.#$:"%;)1;#"-"+,-*$%.,/".0" 51-,$<"2$(3.#(;=;8;):"
  • 2. Resources available for HIVin low and middle income countries, 1986-2010
  • 3. We have done a lot…!  >#3,$?$<$#)$<"(?-8$"93".0"@&7" 3,$$#A.#B"),$-)*$#)B"?-,$"-#<" (933.,)"!  4$?8;#$";#",-)$".0"#$%"@&7" ;#0$?A.#(";#"*-#:"?.9#),;$("!  6.,$")1-#"CDC"*;88;.#"3$.38$".#" !2E"!  6;88;.#(".0".,31-#(",$?$;;#F"=-(;?" $<9?-A.#B"1$-8)1B"(.?;-8"3,.)$?A.#"
  • 4. But we can dobetter5?-8$"93")."<-)$"F9;<$<"=:"-" G?.**.<;):"-33,.-?1H""!  >#(:()$*-A?"3,;.,;A(-A.#"-#<" ;#$()*$#)"%;)1"8;*;)$<"=-(;(";#" ?.9#),:"$3;<$*;.8.F:"-#<"?.#)$I)"!  2$(.9,?$("(3,$-<")1;#8:"-?,.((" *-#:"3-,-88$8";#)$,$#A.#("!  +.?9(".#"<;(?,$)$";#)$,$#A.#(" ,-)1$,")1-#".$,-88",$(98)("8$-<;#F" )."-"0,-F*$#)$<",$(3.#($"
  • 5. New Investment Framework CRITICAL BASIC PROGRAMME ACTIVITIES OBJECTIVES ENABLERS Social enablers Key Children & populations mothers •  Political commitment & Stopping new advocacy •  Laws, policies & infections practices •  Community mobilization Behaviour •  Stigma reduction change Condoms •  Mass media •  Local responses, to change risk environment Programme enablers Keeping •  Community-centered people alive design & delivery •  Programme communication Care & Male •  Management & incentives treatment circumcision •  Production & distribution •  Research & innovation SYNERGIES WITH DEVELOPMENT SECTORS Social protection; Education; Legal Reform; Gender equality; Poverty reduction; Gender-based violence; Health systems (incl. treatment of STIs, blood safety); Community systems; Employer practices.
  • 6. Three investment scenariosImpact on the epidemic %" %! $">54"JK;88;.#(L" $! K9(;#$(("-("9(9-8" #" M"NDO" R$%"@&7"&#0$?A.#(" M"NDP" J*;88;.#(L" #! M"QDO" " M"QDP" M"PDO" ! M"P" $!## $!#$ $!#% $!#& $!#" $!# $!#( $!#) $!#* $!$!
  • 7. Three investment scenariosImpact on the epidemic %" %! $">54"JK;88;.#(L" $! &#$()*$#)"0,-*$%.,/" K9(;#$(("-("9(9-8" #" M"NDO" R$%"@&7"&#0$?A.#(" M"NDP" J*;88;.#(L" #! M"QDO" " M"QDP" M"PDO" ! M"P" $!## $!#$ $!#% $!#& $!#" $!# $!#( $!#) $!#* $!$!
  • 8. Three investment scenariosImpact on the epidemic %" 2-3;<"(?-8$"93" 3,$;.9("3,.S$?A.#(" %! $">54"JK;88;.#(L" $! &#$()*$#)"0,-*$%.,/" K9(;#$(("-("9(9-8" #" M"NDO" R$%"@&7"&#0$?A.#(" M"NDP" J*;88;.#(L" #! M"QDO" " M"QDP" M"PDO" ! M"P" $!## $!#$ $!#% $!#& $!#" $!# $!#( $!#) $!#* $!$!
  • 9. E1$"#$%";#$()*$#)"0,-*$%.,/"+.?9(".#"%1-)"*-/$("-"<;T$,$#?$" >54"JK;88;.#(L" $" $! 5:#$,F;$(" #" V,;A?-8"W#-=8$,(" #! " K-(;?"U,.F,-**$" !?A;A$(" ! $!## $!#$ $!#% $!#& $!#" $!# $!#( $!#) $!#* $!$!
  • 10. ART coverage in 2015 by CD4 count #!!" CD4 350 +!" *!" 15 million )!" (!" V.$,-F$ !" &!" %!" T4P 13.1 million (health) $!" #!" !" ,!! %!-&++ $!-%&+ $!!-$&+ #!!-#++ !-++ .! V4X"V.9#)"J?$88(Y*8L
  • 11. Returns on investment of newinvestment framework (2011-2020) Outcomes Total infections averted More than 12 million Infant infections averted 1.9 million Deaths averted 7.4 million Life years gained 29.4 million
  • 12. New investment framework: the tipping point R$%8:"$8;F;=8$"0.,"),$-)*$#)" R$%8:";#0$?)$<"
  • 13. New infections, behaviour change and treatmentcoverage in Botswana Behaviour change New infections and treatment coverage
  • 14. Cost and economic returns2011 to 2020 Cost/Returns Total additional investment US$46.5 Billion (over 10 years) Future treatment need US$40 Billion averted US$1,060 Life years gained per life year gained
  • 15. Investment framework projections for new HIVinfections Optimized investment will lead to rapid declines in new HIV infections in many countries
  • 16. V.**9#;):"*.=;8;Z-A.#"-((9*3A.#(";#")1$";#$()*$#)"0,-*$%.,/""V.()"$#$8.3$["?.**9#;):"*.=;8;(-A.#"?.*3.#$#)".0")1$" ?,;A?-8"$#-=8$,(""""////$!##//0!1%23/ //$!#/0!1(/23/ / /$!$!/0#1!/23///!((9*3A.#(["•  43567897:/5;<<=3>?@/58A85>?@//•  >3567897:/5;<<=3>?@/976B>57/:7C>B76@///•  377:/D;6/67<=3768E;3/;D/5;<<=3>?@/83:/C8@/F;6G769//•  377:/D;6/?68>3>3HI/H=>:8357I/9=A76B>9>;3/•  A86E5>A8E;3/;D/A7;AC7/C>B>3H/F>?J/K4L/
  • 17. V.**9#;):"*.=;8;Z-A.#["*-/$("(?-8$"93"3.((;=8$"" •  R9*=$,".0"3$.38$")$()$<")1,.9F1"?.**9#;):" *.=;8;Z-A.#"" /$!#!M/&(/<>CC>;3/NLOPQ/// /$!#M/#!+/<>CC>;3// / •  5$,;?$"<$8;$,:"?.()("J),$-)*$#)L"" /$!#!M/0#)+/A76/@786/// /$!$!M/0#$/A76/@786/N0#)/>3/C;F/>35;<7/5;=3?6>79Q// / •  4,;;#F"?.()("<.%#["0$%$,".9)3-A$#)";(;)(B" ?.**9#;):"(933.,)"($,;?$"*.<-8;A$(" •  K$$,"@$-8)1"]9)?.*$("
  • 18. V.**9#;):"*.=;8;Z-A.#["";#?,$-($("$T$?A$#$(("•  O;<<=3>?@/<;2>C>98E;3/>3567897:/K4L/?79E3H/68?79/D;=6- D;C:/>3/P83R83>8I/S><282F7I/T;=?J/UD6>58/83:/PJ8>C83:1///•  O;39>9?73?/5;3:;</=97/>3/A89?/#$/<;3?J9/&/E<79/J>HJ76/>3/ 5;<<=3>E79/F>?J/H;;:/5;<<=3>?@/73H8H7<73?/NV73@8Q////•  K@A;?J7E58C/5>65=<5>9>;3/<;:7C/VF8S=C=-W8?8C/M// –  5;67/>3?76B73E;3M//$&!I!!!/>3D75E;39/8B76?7:/;B76/?73/@7869/ –  F>?J/7382C769M/&$!I!!!/>3D75E;39/8B76?7:I/F>?J/<;:79?/ <86H>38C/>3567897/>3/5;9?9//
  • 19. Investement framework allocation in 2015
  • 20. E-#Z-#;-["-##9-8"#$%"@&7";#0$?A.#(B"NPQQMNPNP" #(!!!!/ #&!!!!/ K-($8;#$"J=9(;#$(("-("9(9-8L" #$!!!!/ #!!!!!/ *!!!!/ (!!!!/ &#$()*$#)"+,-*$%.,/" &!!!!/ $!!!!/ !/ $!##/ $!#$/ $!#%/ $!#&/ $!#/ $!#(/ $!#)/ $!#*/ $!#+/ $!$!/
  • 21. E-#Z-#;-["-##9-8"!&45"<$-)1(B"NPQQMNPNP" #&!!!!/ K-($8;#$"J=9(;#$(("-("9(9-8L" #$!!!!/ #!!!!!/ *!!!!/ (!!!!/ &!!!!/ &#$()*$#)"+,-*$%.,/" $!!!!/ !/ $!##/$!#$/$!#%/$!#&/$!#/$!#(/$!#)/$!#*/$!#+/$!$!/
  • 22. Resources available for HIVin low and middle income countries, globally, 2002-2010
  • 23. Percentage of care and treatmentexpenditure from international sources
  • 24. Few donors meet the development assistance targets Norway 1.10% Luxembourg 1.09% Sweden 0.97% Denmark 0.90% Netherlands 0.81% Belgium 0.64% United Kingdom 0.56% Finland 0.55% Ireland 0.53% France 0.50% Spain 0.43% Switzerland 0.41% Net development assistance Germany 0.38% Canada 0.33% in 2001 as % of gross Austria Australia 0.32% 0.32% national income Portugal 0.29% New Zealand 0.26% United States 0.21% Japan 0.20% Greece 0.17% Italy 0.15% Korea 0.12% 0% 0.3% 0.5% 0.7% 1% 1.2%
  • 25. Measuring national commitment to AIDS:the Domestic Investment Priority IndexSOURCE: UNAIDS expenditure data; WHO data on the burden disease; and economic data from the International Monetary Fund World Economic Outlook database
  • 26. Economic growth in Africa, 1970–2010Third-fastest growing region in the World
  • 27. Three options for increasing domestic public HIVinvestment in Africa
  • 28. Projected resource needs (in USD billion)Assumed increases of domestic contributions by BRICS and otherswithin ability to pay (economic growth and towards Abudja targets) Development Assistance 8.0 10.7 9.4 12.7 11.8 13.6 13.5 13.0 11.9 11.3 Domestic financing 9.7 LI LMI UMI XY4OT/
  • 29. T;<7/Z=79E;39 /•  [J8?/867/?J7/9?68?7H>5/;A73>3H9/D;6/8/37F/ :>8C;H=7/86;=3:/75>735@]/•  U67/?J767/;2B>;=9/<>9-<8?5J79/27?F773/?J7/ 7A>:7<>5/83:/?J7/679A;397]/•  [J>5J/867/?J7/D85?;69/?J8?/<8G7/>?/:>5=C?/?;/ 958C7/=A/289>5/A6;H68<<7/5;<A;373?9]//•  K;F/5;=C:/A86?3769/J7CA/>3/8AAC>58E;3/;D/?J7/ 4^/8AA6;85J/
  • 30. The beginning of the end ofAIDS is in our hands
  • 31. Y785J>3H/A7;AC7/F>?J/976B>579M / _`8<AC79/D;6/$!#/ V.$,-F$" J3.398-A.#",$-?1$<L "O;3:;<9/N:>95;6:83?/5;=AC79Q/ (!" /O;3:;<9/NJ>HJ/6>9G/A;AQ/ !" /T7`/F;6G/ (!" /aTa/A6;H68<<79/ (!" /4bc/A6;H68<<79/ (!" / 6;88;.#"K4L/?79E3H/ %$! /UYP/NOb&/%!I/P&dQ/ ?;F86:9/# /
  • 32. O;9?/A76/A8E73?/A76/@786/ / NF7>HJ?7:/8B768H7/>3/cT0Q / " " " " "NPQP " "NPQO " "NPNP"/e82/N37F/A8E73?9Q/////// /#*!//// / /#$+/ / /)+///e82/N5;3?/A8E73?9Q//////// /#*!/ / /#$*/ / /)(///T76B>57/:7C>B76@/ / /#)(/ / /#&&/ / /##$///#9?/e>37/UYL9/ / / /# / /#&)/ / /)///$3:/e>37/UYL9/ / / /#()* / /+*& / /$+//
  • 33. P79E3H/83:/O;=397C>3H / O;B768H7/83:/5;9?/A76/A769;3/ !"#$%&(%)*+,$%)"-,#**.%/,.%$#$.0:109108107106105104103102101 1; 6; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 26 36 46 56 66 76 86 96 :6 12 14 16 31 51 86 1< 1< 1< 1< 1< 1< !"=(/>
  • 34. fTP/O;9?/U99=<AE;39 /V.()".0"6$)1-<.#$[""•  %%5/D;6/*!<H/>3/4683/?;/0$1!(/D;6/*!<H/>3/ 43:;379>8/•  U2;=?/cTb/#!!!/A76/A769;3/@786/•  g;>3H/:;F3/2@/$!"/>3/$!#/83:/2@/J8CD/>3/ $!$!/
  • 35. X7J8B>;6/OJ83H7/d6;H68<<79 /•  e>hC7/7B>:7357/D;6/7i75EB73799/•  e>hC7/>3D;6<8E;3/;3/5;9?/•  U9/8/A6;`@M/5;9?/F;6GAC857/A6;H68<9/N2@/$!#I/ !"/5;B768H7/;D/?J7/#&*/<>CC>;3/7<AC;@779/>3/ ?J7/D;6<8C/975?;6/>3/5;=3?6>79/F>?J/ H73768C>R7:/7A>:7<>59I/8B768H7/=3>?/5;9?/;D/cT 0/+/A76/7<AC;@77/A76/@786Q//
  • 36. O;<<=3>?@/a;2>C>R8E;3/•  e>hC7/>3D;6<8E;3/;3/5;9?/ /•  O;=3?6@/67B>7F9/NcTb/#/?;/#&/A76/8:=C?/ A;A=C8E;3Q/ /•  O;<<=3>?@/K78C?J/[;6G769/Nj/cTb/$/A76/ 8:=C?/A;A=C8E;3Q//